Why Mounjaro and Gastroparesis Are a Risky Combination The primary concern with using Mounjaro in the presence of gastroparesis is the risk of severe gastrointestinal complications
These include nutritional guidance, physical activity, emotion regulation skills, and self-monitoring, which are core components of both post-bariatric and general obesity programs
There Isnt One Official GLP-1 Diet Despite the name, there isnt an official GLP-1 diet endorsed by healthcare organisations or medication manufacturers
Deng QQ, Sheng WL, Zhang G, Weng SJ, Yang XL, Zhong YM
The key results: 13.6% average weight loss with oral semaglutide, compared to 2.2% with placebo 76.3% of people on the pill achieved at least 5% weight loss, compared to 31.3% on placebo 55.6% achieved at least 10% weight loss Around 30% achieved 20% or more weight loss Theres an important distinction in how these results are reported
Role of single nucleotide variants in the YAP1 gene in adolescents with polycystic ovary syndrome